NCT03515577View on ClinicalTrials.gov

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

April 25, 2019

Study Completion Date

April 25, 2019

Conditions
Recurrent Prostate Carcinoma
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

Fluciclovine F18

Given fluciclovine F18

DRUG

Gallium Ga 68-labeled PSMA-11

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT03515577 - Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery | Biotech Hunter | Biotech Hunter